COHERUS BIOSCIENCES, INC.

Lobbying for COHERUS BIOSCIENCES, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 expenses · posted May 18, 2026

Lobbying activity 2

Health Issues

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production

Government Issues

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.